Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1987 Feb;55(2):403–408. doi: 10.1128/iai.55.2.403-408.1987

Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.

L Choromanski, R E Kuhn
PMCID: PMC260341  PMID: 2948917

Abstract

Mice infected with Trypanosoma cruzi exhibit an early and profound suppression of parasite-specific and nonspecific immune responses. Earlier studies have shown that this suppression is due, at least in part, to suppressor macrophages, deficiency in production of interleukin-2 (IL-2), and reduced T helper (Th)-cell activity. In the present study, the effect of exogenously supplied IL-2 on enhancement of parasite-specific Th-cell activity, anti-parasite immunoglobulin G (IgG) and IgM antibody levels, parasitemia, and longevity was examined in infected mice. The results showed that administration of IL-2 with and without antigenic stimulation with trinitrophenylated T. cruzi significantly enhanced parasite-specific IgM and IgG levels. Injection of IL-2 and trinitrophenylated T. cruzi together significantly enhanced parasite-specific Th-cell activity and was more effective in enhancement of parasite-specific antibody levels. In addition, it was found that IL-2 alone had a rapid and lasting effect in reducing parasitemia. These results suggest that deficiency in IL-2 may play a major role in host susceptibility to T. cruzi.

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burgess D. E., Kuhn R. E., Carlson K. S. Induction of parasite-specific helper T lymphocytes during Trypanosoma cruzi infections in mice. J Immunol. 1981 Nov;127(5):2092–2095. [PubMed] [Google Scholar]
  2. Choromanski L., Kuhn R. E. Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease. Infect Immun. 1985 Nov;50(2):354–357. doi: 10.1128/iai.50.2.354-357.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clinton B. A., Ortiz-Ortiz L., Garcia W., Martinez T., Capin R. Trypanosoma cruzi: early immune responses in infected mice. Exp Parasitol. 1975 Jun;37(3):417–425. doi: 10.1016/0014-4894(75)90012-0. [DOI] [PubMed] [Google Scholar]
  4. Cunningham D. S., Kuhn R. E., Rowland E. C. Suppression of humoral responses during Trypanosoma cruzi infections in mice. Infect Immun. 1978 Oct;22(1):155–160. doi: 10.1128/iai.22.1.155-160.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cunningham D. S., Kuhn R. E. Trypanosoma cruzi-induced suppression of the primary immune response in murine cell cultures to T-cell-dependent and -independent antigens. J Parasitol. 1980 Feb;66(1):16–27. [PubMed] [Google Scholar]
  6. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  7. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3466–3469. doi: 10.1073/pnas.80.11.3466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jerne N. K., Henry C., Nordin A. A., Fuji H., Koros A. M., Lefkovits I. Plaque forming cells: methodology and theory. Transplant Rev. 1974;18:130–191. doi: 10.1111/j.1600-065x.1974.tb01588.x. [DOI] [PubMed] [Google Scholar]
  9. Kierszenbaum F. Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells. J Immunol. 1982 Nov;129(5):2202–2205. [PubMed] [Google Scholar]
  10. Kuhn R. E., Murnane J. E. Trypanosoma cruzi: immune destruction of parasitized mouse fibroblasts in vitro. Exp Parasitol. 1977 Feb;41(1):66–73. doi: 10.1016/0014-4894(77)90130-8. [DOI] [PubMed] [Google Scholar]
  11. Kuhn R. E., Vaughn R. T., Herbst G. A. The effect of BCG on the course of experimental Chagas' disease in mice. Int J Parasitol. 1975 Oct;5(5):557–560. doi: 10.1016/0020-7519(75)90049-1. [DOI] [PubMed] [Google Scholar]
  12. Mitchison N. A. The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis. Eur J Immunol. 1971 Jan;1(1):10–17. doi: 10.1002/eji.1830010103. [DOI] [PubMed] [Google Scholar]
  13. OVARY Z., BENACERRAF B. IMMUNOLOGICAL SPECIFICITY OF THE SECONDARY RESPONSE WITH DINITROPHENYLATED PROTEINS. Proc Soc Exp Biol Med. 1963 Oct;114:72–76. doi: 10.3181/00379727-114-28589. [DOI] [PubMed] [Google Scholar]
  14. Powell M. R., Kuhn R. E. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure. J Parasitol. 1980 Jun;66(3):399–406. [PubMed] [Google Scholar]
  15. Reed S. G., Inverso J. A., Roters S. B. Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2. J Immunol. 1984 Sep;133(3):1558–1563. [PubMed] [Google Scholar]
  16. Reed S. G., Inverso J. A., Roters S. B. Suppressed antibody responses to sheep erythrocytes in mice with chronic Trypanosoma cruzi infections are restored with interleukin 2. J Immunol. 1984 Dec;133(6):3333–3337. [PubMed] [Google Scholar]
  17. Reed S. G., Larson C. L., Speer C. A. Suppression of cell-mediated immunity in experimental Chagas' disease. Z Parasitenkd. 1977 Jun 3;52(1):11–17. doi: 10.1007/BF00380553. [DOI] [PubMed] [Google Scholar]
  18. Reed S. G., Roters S. B., Goidl E. A. Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice. J Immunol. 1983 Oct;131(4):1978–1982. [PubMed] [Google Scholar]
  19. Rowland E. C., Kuhn R. E. Suppression of cellular responses in mice during Trypanosoma cruzi infections. Infect Immun. 1978 May;20(2):393–397. doi: 10.1128/iai.20.2.393-397.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Snary D., Hudson L. Trypanosoma cruzi cell surface proteins: identification of one major glycoprotein. FEBS Lett. 1979 Apr 1;100(1):166–170. doi: 10.1016/0014-5793(79)81156-4. [DOI] [PubMed] [Google Scholar]
  21. Snary D. Trypanosoma cruzi: antigenic invariance of the cell surface glycoprotein. Exp Parasitol. 1980 Feb;49(1):68–77. doi: 10.1016/0014-4894(80)90057-0. [DOI] [PubMed] [Google Scholar]
  22. Tarleton R. L., Kuhn R. E. Measurement of parasite-specific antibody responses using a tritiated avidin-solid phase radioimmunoassay. J Immunol Methods. 1983 May 27;60(1-2):213–220. doi: 10.1016/0022-1759(83)90349-6. [DOI] [PubMed] [Google Scholar]
  23. Tarleton R. L., Kuhn R. E. Measurement of parasite-specific immune responses in vitro: evidence for suppression of the antibody response to Trypanosoma cruzi. Eur J Immunol. 1985 Aug;15(8):845–850. doi: 10.1002/eji.1830150820. [DOI] [PubMed] [Google Scholar]
  24. Tarleton R. L., Kuhn R. E. Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. J Immunol. 1984 Sep;133(3):1570–1575. [PubMed] [Google Scholar]
  25. Tarleton R. L., Schulz C. L., Grögl M., Kuhn R. E. Diagnosis of Chagas' disease in humans using a biotin-3H-avidin radioimmunoassay. Am J Trop Med Hyg. 1984 Jan;33(1):34–40. doi: 10.4269/ajtmh.1984.33.34. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES